Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Androgen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07745361
What this trial is testing

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Castration-Resistant Prostate CancerProstate Cancer+1 more
Monte Rosa Therapeutics, Inc 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06836726
What this trial is testing

Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
University Health Network, Toronto 35
Post-approval studies (Phase 4)Study completedNCT02485691
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Who this might be right for
Prostate Cancer Metastatic
Sanofi 255
Testing effectiveness (Phase 2)UnknownNCT02910050
What this trial is testing

Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Xu fei 58
Testing effectiveness (Phase 2)Study completedNCT00303446
What this trial is testing

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

Who this might be right for
Kennedy's DiseaseSpinal and Bulbar Muscular Atrophy
National Institute of Neurological Disorders and Stroke (NINDS) 57
Not applicableStudy completedNCT06902441
What this trial is testing

Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database

Who this might be right for
Prostate Cancer
University Hospital, Caen 52,000
Early research (Phase 1)Study completedNCT02924766
What this trial is testing

A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 34
Early research (Phase 1)UnknownNCT01239888
What this trial is testing

Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study

Who this might be right for
DepressionMajor Depressive Disorder
The Alfred 15
Testing effectiveness (Phase 2)Study completedNCT01251861
What this trial is testing

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7+2 more
National Cancer Institute (NCI) 108
Not applicableLooking for participantsNCT05647564
What this trial is testing

PET/CT Characterization of Treatment Resistance

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 25
Not applicableUnknownNCT05157373
What this trial is testing

The Effect of Androgen Receptor Polymorphism on Endometrial Cancer

Who this might be right for
Androgen Receptor AbnormalEndometrial Disorder
University of Nicosia 150
Early research (Phase 1)Ended earlyNCT03300505
What this trial is testing

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT03383679
What this trial is testing

Study on Androgen Receptor and Triple Negative Breast Cancer

Who this might be right for
Breast Cancer FemaleTriple Negative and Androgen Receptor Positive
UNICANCER 94
Testing effectiveness (Phase 2)Looking for participantsNCT06457919
What this trial is testing

Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 50
Not applicableUnknownNCT04710186
What this trial is testing

AR, IGF-IR, IR and Peripheral Artery Disease

Who this might be right for
Androgen Receptor AbnormalInsulin-Like Growth Factor I DeficiencyInsulin Receptor, Defect in
University of Catanzaro 30
Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Testing effectiveness (Phase 2)Looking for participantsNCT07226713
What this trial is testing

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 32
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Testing effectiveness (Phase 2)WithdrawnNCT01612910
What this trial is testing

Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

Who this might be right for
Breast Cancer Female
Barbara Ann Karmanos Cancer Institute
Post-approval studies (Phase 4)Active Not RecruitingNCT06908694
What this trial is testing

Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Hamilton Health Sciences Corporation 20
Next Page